Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
Gerald Hogue (1) ​ ​ ​ ​ 63 ​ ​ ​ Class III Director ​ David C. Lubner (2) ​ ​ ​ ​ 56 ​ ​ ​ Class II Director ​ Dr. Yael Margolin, Ph.D. (1) ​ ​ ​ ​ 68 ​ ​ ​ Class II Director ​ Executive Officers Dr. Joe McCann, Ph.D. has served as Chief Executive Officer of Old POINT since January 2020 and of New POINT since June 2021 and as a member of the board of directors of Old POINT since September 2019 and of New POINT since June 2021. Dr. McCann has overall responsibility for the day-to-day operations of New POINT. Prior to this role, from May 2010 until December 2019, Dr. McCann held various roles of increasing responsibility at the Centre for Probe Development and Commercialization (CPDC), most recently as Chief Executive Officer and President, where he led the formation and growth of the company’s contract development and manufacturing operations and the build out of radiopharmaceutical manufacturing facilities. Prior to joining CPDC, Dr.
This record is keyed to SEC CIK 0001868738 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 150 institutional-holder rows on these vehicles, under 46 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.